The remaining 15 subjects reported taking either or a combination of the following medications: high blood pressure medications (beta-, angiotensin receptor-, calcium channel-blockers, ACE inhibitors) and/or statins (16%), anti-depressants/SSRI (4%; note: all subjects washed off anti-depressants for at least 2 weeks before FDG-PET), prostate medications (4%), hormone replacement therapy (9%). Here, ACE is linked to hypertensive disorder.